Chaudhry Navila Talib, Franklin Bryony Dean, Mohammed Salmaan, Benn Jonathan
Research Department of Practice and Policy, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK.
Centre for Medication Safety and Service Quality, Pharmacy Department, Imperial College Healthcare NHS Trust, London W6 8RF, UK.
Pharmacy (Basel). 2021 Dec 13;9(4):198. doi: 10.3390/pharmacy9040198.
To conduct a systematic review and narrative synthesis of interventions based on secondary use of data (SUD) from electronic prescribing (EP) and electronic hospital pharmacy (EHP) systems and their effectiveness in secondary care, and to identify factors influencing SUD.
The search strategy had four facets: 1. Electronic databases, 2. Medication safety, 3. Hospitals and quality/safety, and 4. SUD. Searches were conducted within EMBASE, Medline, CINAHL, and International Pharmaceutical Abstracts. Empirical SUD intervention studies that aimed to improve medication safety and/or quality, and any studies providing insight into factors affecting SUD were included.
We identified nine quantitative studies of SUD interventions and five qualitative studies. SUD interventions were complex and fell into four categories, with 'provision of feedback' the most common. While heterogeneous, the majority of quantitative studies reported positive findings in improving medication safety but little detail was provided on the interventions implemented. The five qualitative studies collectively provide an overview of the SUD process, which typically comprised nine steps from data identification to analysis. Factors influencing the SUD process were electronic systems implementation and level of functionality, knowledge and skills of SUD users, organisational context, and policies around data reuse and security.
The majority of the SUD interventions were successful in improving medication safety, however, what contributes to this success needs further exploration. From synthesis of research evidence in this review, an integrative framework was developed to describe the processes, mechanisms, and barriers for effective SUD.
对基于电子处方(EP)和电子医院药房(EHP)系统的数据二次利用(SUD)干预措施及其在二级医疗保健中的有效性进行系统评价和叙述性综合分析,并确定影响数据二次利用的因素。
检索策略有四个方面:1. 电子数据库;2. 用药安全;3. 医院与质量/安全;4. 数据二次利用。检索在EMBASE、Medline、CINAHL和国际药学文摘数据库中进行。纳入旨在提高用药安全和/或质量的实证性数据二次利用干预研究,以及任何提供影响数据二次利用因素见解的研究。
我们确定了9项关于数据二次利用干预措施的定量研究和5项定性研究。数据二次利用干预措施很复杂,分为四类,其中“提供反馈”最为常见。虽然研究具有异质性,但大多数定量研究报告在改善用药安全方面有积极结果,但对所实施的干预措施提供的细节很少。这5项定性研究共同概述了数据二次利用过程,该过程通常包括从数据识别到分析的9个步骤。影响数据二次利用过程的因素包括电子系统的实施和功能水平、数据二次利用用户的知识和技能、组织背景以及围绕数据再利用和安全的政策。
大多数数据二次利用干预措施在改善用药安全方面取得了成功,然而,促成这一成功的因素需要进一步探索。通过对本综述中研究证据的综合分析,开发了一个综合框架来描述有效数据二次利用的过程、机制和障碍。